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Understanding the Heterogeneity 
of Mitral Regurgitation Is Essential 
for a Correct Diagnosis
Mitral regurgitation is a frequent disease1-4) diagnosed in the 
presence of a pathological amount of blood regurgitating from 
the left ventricle into the left atrium due to mitral valve in-
competence usually–but not exclusively–occurring during 
systole.5) Mitral regurgitation can occur even in diastole when 
is present an atrio-ventricular block, pace-makers with short 
atrio-ventricular delay, and/or significantly elevated left ven-
tricular filling pressures.6)
Once we have diagnosed the presence of MR we should try 
to assign it an etiology, which can be either ischemic or non-isch-
emic. The assessment of the etiology is particularly important, 
since different etiologies imply different criteria of severity, 
different prognosis, and may deserve different treatments.7)8) 
Multiple etiologies can coexist in the same patient, and in that 
case it is worth trying to identify the one prevalent. Having 
established the etiology, the following duty is to recognize the 
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mechanism, which can be either organic or functional. Organ-
ic is MR caused by intrinsic anatomic abnormalities affecting 
the mitral valve itself or its sub-valvular apparatus (for instance 
myxomatous degeneration, rheumatic disease, aging process, 
or endocarditis) (Supplementary Fig. 1, 2, and 3). If we exclude 
an intrinsic lesion, we should than direct our attention to the 
left ventricle and the mitral annulus, since we are likely facing 
functional MR. In functional MR, the valve and the sub-valvu-
lar apparatus are macroscopically normal, and the incompe-
tence is mainly due to altered geometrical relationships be-
tween a diseased ventricle and the mitral valve apparatus 
(Supplementary Fig. 4).9) The subsequent diagnostic step is 
classifying the “type of dysfunction”. The type of dysfunction is 
identified by the systolic position of the margin of the leaflets 
with respect to the plane of the annulus.10) Accordingly, we can 
have three types of dysfunction: Type 1, normal motion of the 
leaflets with isolated annular dilatation causing poor leaflet co-
aptation; Type II, excess motion of the margin of a leaflet seg-
ment above the annular plane; Type III, restricted motion of the 
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Knowledge of mitral regurgitation (MR) is essential for any care provider, and not only for those directly involved in the manage-
ment of cardiovascular diseases. This happens because MR is the most frequent valvular lesion in North America and the second 
most common form of valve disease requiring surgery in Europe. Furthermore, due to the ageing of the general population and the 
reduced mortality from acute cardiovascular events, the prevalence of MR is expected to increase further. Doppler echocardiogra-
phy is essential both for the diagnosis and the clinical management of MR. In the present article, we sought to provide a practical 
step-by-step approach to help either performing a Doppler echocardiography or interpreting its findings in light of contemporary 
knowledge on organic (but not only) MR.
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leaflets during both diastole and systole (Type IIIa) or during 
systole only (Type IIIb). The identification of the type of dys-
function is particularly common among surgeons, since it gives 
insights for selecting specific operative techniques. 
How Doppler Echocardiography Relates 
to Clinical Findings and to Some 
of the Other Most Commonly Available 
Diagnostic Techniques of Imaging
Assessment of the severity of any valvular lesion (including 
MR) is crucial for decision-making and should always be based 
on the combination of clinical and instrumental findings.11) 
No single technique suffices if not integrated by a carefully col-
lected past medical history and combined with an accurate 
physical examination.11)
Physical examination represents the first step in the diagnosis 
of MR severity. Detection of a murmur with a low intensity usu-
ally suggests mild MR, whereas a loud murmur usually indi-
cates severe regurgitation.12) Unfortunately, in many cases the 
murmur is of a medium intensity, which can be generated ei-
ther by severe or moderate MR.12) Cardiac auscultation is even 
more challenging in functional MR,13) where severe regurgita-
tion can be completely silent.14)15) Electrocardiogram (ECG) and 
the chest X-ray are usually performed alongside clinical exam-
ination in almost every patient and may sometimes provide 
additional information. Cardiac enlargement and/or pulmonary 
congestion at chest X-ray is consistent with severe regurgita-
tion, as well as the detection of left atrial enlargement or atrial 
fibrillation at the ECG. 
In the past, when non invasive clinical/instrumental assess-
ment was consistent with significant MR, physicians tradition-
ally performed a ventricular angiogram to direct subsequent 
decision making. This technique is based on the degree of opaci-
fication of the left atrium caused by the reurgitant jet, and the 
degree is generally graded using a scale from 1+ (mild) to 4+ 
(severe).16) Although angiography has been considered for many 
years the gold standard for the assessment of MR, this diagnos-
tic tool is characterized by a significant overlap between grades, 
particularly in presence of large volumes of regurgitation, when 
a correct assessment is mandatory to guide surgical indica-
tions.16)17) Furthermore, since the injection of contrast needs to 
be rapid enough to allow a proper opacification of the left ven-
tricle, such technical requirement may lead to premature ven-
tricular contractions, eventually causing imprecise assessments. 
Analogously, an improper positioning of the pig tail catheter 
can interfere with the sub-valvular apparatus causing an over-
estimation of MR severity. 
Moving toward non-invasive assessments of valvular lesions, 
magnetic resonance imaging (MRI) is emerging as a useful di-
agnostic tool. The evaluation of the mitral valve from routinely 
acquired MRI imaging is often inadequate, but the introduction 
of protocols specifically designed can achieve a notable diagnos-
tic accuracy.18) In patients with organic MR, MRI can contribute 
to identify the mechanism of the lesion and the predictability 
of the repair (recent reports found a sensitivity and specificity 
of MRI in identifying a flail or prolapsing leaflets approaching 
90%).19) In functional MR, MRI can exclude the presence of 
coexisting degenerative lesions, assess myocardial viability and 
analyze regional wall motion abnormalities. The assessment of 
the amount of regurgitation trough MRI can be achieved through 
different methods. For instance, we can calculate the regurgitant 
volume and regurgitant fraction by measuring the left ventric-
ular and aortic stroke volumes. Furthermore, we can search for 
the presence of systolic reversal in the pulmonary veins, a spe-
cific sign of severe MR (see also the following paragraph). Final-
ly, MRI can assess the consequences of volume overload through 
an accurate evaluation of cardiac volumes and function. Unfor-
tunately, in addition to the limitation due to respiration, MRI 
is expensive and time consuming, and consequently mostly avail-
able in tertiary centers only.
Anatomy and Physiopathology of Mitral 
Regurgitation by Echocardiography
We believe that Doppler echocardiography represents the 
gold standard for the diagnosis of MR, providing non-invasive-
ly reliable information on the presence of the lesion, its etiolo-
gy, the mechanism, the dysfunction and the severity of regur-
gitation. This happens because, two-dimensional (2-D) and 
three-dimensional (3-D) echocardiography can supply precise 
details about the functional anatomy of the leaflets, the chordae 
tendineae, the annulus, the papillary muscle and their support-
ing walls. 
In organic MR, 2-D echocardiography helps to guide diag-
nosis toward the identification of a specific etiology of regurgi-
tation (degenerative, rheumatic, infective endocarditis etc.). 
For any given etiology we should than expect a definite group 
of potential mechanisms. Classic features of Barlow’s disease 
that can be detected by 2-D echocardiography include excess 
tissue in multiple segments, chordal thickening, annular dila-
tation and a tendency to calcification (Supplementary Fig. 1). 
The mechanism of regurgitation usually associated with Bar-
low’ disease lesions is chordal elongation (Type II dysfunction). 
On the opposite side from Barlow’s disease, fibroelastic defi-
ciency is remarkable for chordal thinning, resulting in elonga-
tion and rupture. As regards a rheumatic etiology (Supple-
mentary Fig. 2), mitral leaflets commissures and sub valvular 
apparatus are usually thickened, in association with varying de-
grees of calcification. In these patients, MR can be combined 
with stenotic lesions, resulting in the classic hockey stick ap-
pearance of the anterior mitral leaflet in diastole and reduced 
mobility of the posterior leaflet. Concerning endocarditis, the 
diagnostic clue is represented by the imaging of vegetations ap-
pearing as an echogenic mobile masses attached to the valvular 
leaflets (Supplementary Fig. 3). Usually, vegetations are initial-
ly attached to the atrial side, and become identifiable by trans-
thoracic examination only when they reach 3–5 mm in diameter. 
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The potential mechanisms of the lesion caused by endocarditis 
include rupture or perforation of the leaflet. 
In organic MR, 2-D echocardiography can also support the 
diagnosis of severity. In long-standing severe regurgitation, left 
atrial and ventricular volumes need to be dilated; conversely nor-
mal cardiac volumes in patients diagnosed as having chronic 
severe MR should raise concerns regarding the diagnostic accu-
racy. Similarly, the presence of a prominent flail or a ruptured 
papillary muscle by 2-D echocardiography (Supplementary 
Fig. 1) should be interpreted as a specific sign of severe MR. 
On the other hand, the detection of enlarged cardiac chambers 
associated with only a mild amount of regurgitation should raise 
the suspicion of an underestimation of the degree of MR or make 
us searching for an associated disease resulting in cardiac en-
largement. 
If segmental analysis by transthoracic study is not diagnos-
tic (Fig. 1-5), trans-esophageal echocardiography (TEE) can 
help in visualizing the cardiac structures and in delineating more 
in detail the mechanism of MR (Supplementary Fig. 5).20) 
More recently, real time 3-D echocardiography has contribut-
ed to further improve the communication between clinicians 
and surgeons by offering a surgical view of the mitral valve 
(Fig. 5-8). By 3-D TEE, we can assess diameters and height 
of the mitral annulus, mitral leaflet surface, the angle between 
the aortic and the mitral annulus, and the distance between the 
mitral commissures and the papillary muscles. In selected cas-
es, the measurements of these parameters may enhance the 
understanding of the mechanism of regurgitation and facili-
tate the surgical planning.21)
Fig. 1. Parasternal long axis view by transthoracic echocardiography. 
Segmental analysis of the mitral valve. AV: aortic valve, LA: left atrium, 
LV: left ventricle, RV: right ventricle, VS: ventricular septum (see also 
Fig. 5).
Fig. 3. Four chambers apical view by transthoracic echocardiography. 
Segmental analysis of the mitral valve. LA: left atrium, LV: left ventricle, 
RA: right atrium, RV: right ventricle, VS: ventricular septum (see also 
Fig. 5).
Fig. 2. Parasternal short axis view by transthoracic echocardiography. 
Segmental analysis of the mitral valve. RV: right ventricle, VS: ventricular 
septum (see also Fig. 5).
Fig. 4. Two chambers apical view by transthoracic echocardiography. 
Segmental analysis of the mitral valve. LA: left atrium, LV: left ventricle 
(see also Fig. 5).
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Assessment of Severity by Doppler 
Echocardiography
The visualization of the jet area by color flow imaging pro-
vides a rapid screening of the presence and direction of the re-
gurgitant jet. In general, larger jet areas visualized by color flow 
imaging correspond to larger volumes of regurgitation. Accord-
ingly, a semi quantitative assessment of MR can be obtained 
trough the assessment of the jet area and of the ratio jet area/
left atrium area (Supplementary Fig. 6).20) Usually this analysis 
requires an aliasing velocity of 50–60 cm/sec and a color gain 
set to eliminate random color speckle from the regions with-
out movements. It is also very important to obtain the largest 
image of the variables of interest (i.e., the left atrium and the 
jets). This technical tip facilitates tracing and reduce the influ-
ence of potential mistakes. The left atrium and the jets are 
measured by an apical 4-chambers view and long axis view. 
The thresholds for defining MR severity according to regurgi-
tant jet and jet/atrial area ratio are reported in Supplementary 
Fig. 6C and D. Unfortunately, color flow imaging underesti-
mates MR in eccentric jets and overestimates central jets. Fur-
thermore, gain and filter setting can additionally interfere with 
MR assessment performed by color flow imaging. 
The jet is characterized at its emergence from the leaflets by 
the presence of a narrow zone corresponding to contraction of 
the blood flow into the anatomic regurgitant orifice (the nar-
rowest portion of the jet).22) This “neck” of the jet is defined as 
vena contracta, and its measurement provides an indirect as-
sessment of the regurgitant orifice (Supplementary Fig. 7). On 
the clinical field,–due to the physical properties of ultra-
sounds–the measurement of vena contracta width should be 
performed using parasternal long-axis views in order to take 
advantage of the spatial resolution. It is also very important to 
use the zoom combined with a narrow sector of color flow, in 
order to obtain the best visualization and high frame rate. The 
transducer should be positioned trying to visualize the proxi-
mal flow acceleration, the vena contracta and the downstream 
expansion of the jet. In the case of atrial fibrillation, it is impor-
tant to average the measurements for several cardiac cycles. 
The thresholds for defining MR severity according to vena con-
tracta is reported in Supplementary Fig. 7B.20) Although vena 
contracta width in the context of a fixed orifice is relatively in-
A
B
Fig. 5. Surgical view of the mitral valve (A). Spatial orientation of the most 
commonly used two-dimensional transthoracic echocardiographic 
views (B). Leaflet segmentation starts with A1-P1 close to the anterolateral 
commissure, A2-P2 centrally, and A3-P3 close to the posteromedial 
commissure. 
Fig. 6. Three-dimensional trans-esophageal 
echocardiography facilitates evaluation of 
mitral valve leaflets. Cross-plane of the 
surgical view makes easier to measure the 
prolapse height of every segments. At the 
bottom in the figure, sagittal view of the 
valve at different levels. The annular plane 
is highlighted by the dotted line.
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dependent of flow rate and driving pressures,23) in dynamic or-
ifices it changes according to hemodynamics and cardiac cycle.24) 
The separation of the vena contracta itself from the MR jet, 
usually obtained in parasternal long axis view, requires consid-
erable practice. Furthermore, since the regurgitant orifice is of-
ten elongated along the mitral coaptation line, the views paral-
lel to the line of coaptation tend to show a wide area of vena 
contracta even in mild MR.20)
A quantitative assessment of a regurgitant lesion, regardless 
of the method, imply the calculation of effective regurgitant ori-
fice area (EROA), regurgitant volume (RVol), and regurgitant 
fraction (RF). The EROA is a measure of the lesion severity. 
The RVol identifies the volume regurgitated. The RF corre-
sponds to the volume regurgitated in comparison with the to-
tal ventricular stroke volume.21) Quantitative indices should be 
assessed through different echocardiographic methods in order 
to provide reliable results. Among the latter, the most commonly 
used method is proximal isovelocity surface area (PISA) (Supple-
mentary Fig. 8).25) When blood during the process of regurgi-
tation goes from the left ventricle into the left atrium, on con-
verging toward the mitral valve it gradually accelerates, 
producing a series of hemisphere-like shells. As we come closer 
to the orifice of regurgitation, these hemispheres progressively 
increase in velocity and decrease in surface area. Because of the 
principle of the conservation of mass, the product of the sur-
face multiplied by the velocity is a constant. Therefore, the prod-
uct of the surface multiplied by the velocity at the level of any 
given identified hemisphere in proximity of the regurgitant or-
ifice is equal to the product of the velocity multiplied by the sur-
face at the level of the EROA (the variable of interest). In clini-
cal practice, to use PISA we should image from an apical window. 
After optimizing the 2-D image, zoom can help improving 
the detail of the color flow at the level of the flow convergence 
region. Then, shifting the baseline of the color scale downward 
(optimal aliasing velocity varies for each patient), we can in-
crease the size of the hemisphere. A small size of the hemisphere 
amplifies the effects of errors in measurement of the radius. Col-
or baseline adjustment can help to obtain the correct shape, 
Fig. 7. Multiplanar reconstruction of mitral valve regurgitation using 3-dimensional (3-D) color Doppler full-volume acquisition by transesophageal 
echocardiography. Multiple simultaneous orthogonal 2-dimensional-like slices are presented in multiplanar reformatting mode, showing the long-axis 
cut planes (A and B) and the short-axis cut plane parallel to the mitral annulus (C). D: Reformatted 3-D volume illustrating the regurgitant jet. In panel 
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which is a portion of a sphere, because lateral flows at angles 
close to 90° to the ultrasound beam are not visible. We can 
identify a hemisphere approaching the effective regurgitant 
orifice and calculate its area as 2πr2 (where r = radius of the 
measured shell) and record the velocity of the selected hemi-
sphere (which is given by the machine as aliasing velocity). To 
proceed further, we can obtain the velocity at the level of the 
regurgitant orifice (which corresponds to the maximal velocity 
of the regurgitant jet measured by continuous wave Doppler). 
At this stage, we have obtained all we need to calculate the 
EROA. It is worth noticing that the measure of the radius of 
the hemisphere should be obtained at the same moment of the 
cardiac cycle when velocity of regurgitation is recorded.
Since:
The area of the hemisphere multiplied by the aliasing veloc-
ity = EROA multiplied by peak MR velocity 
Consequently:
EROA = (2πr2 multiplied by aliasing velocity) divided by 
peak MR velocity
Regurgitant volume can be obtained by multiplying EROA 
by regurgitant time velocity integral.
PISA limitations include partial applicability in multiple jets 
and limited accuracy in eccentric jets, which are characterized 
by a difficult Doppler alignment. 
The rationale of quantitative Doppler in MR is that in the ab-
sence of significant aortic regurgitation, the difference between 
the inflow at the level of the mitral valve and the outflow at the 
level of the aorta is equal to the RVol. In quantitative 2-D echo-
cardiography, we use the same principle but instead of the mi-
tral valve inflow volume we use the stroke volume of the left ven-
tricle calculated by biapical Simpson rule.20)
The most common pitfall of quantitative Doppler is the over-
estimation of mitral valve stroke volume, due to incorrect posi-
tioning of the Doppler sample at the level of the mitral leaflets. 
Concerning 2-D echocardiography, improper MR assessment 
usually derives from incorrect measurements of ventricular vol-
Fig. 8. A and B: Multiplane 2-dimensional transesophageal echocardiogram showing commissural view without (A) and with (B) color Doppler. A: 
From left to right three scallops of the mitral valve are evident postero-medial commissural scallop (arrow), middle segment of anterior leaflet (A2) and 
lateral segment of posterior leaflet (P1). B: Mitral regurgitation with eccentric jet from the postero-medial commisure direct toward the left appendage. 
C and D: Real time 3-dimensional (3-D) transesophageal echocardiography. C: Left atrial view (“en face” surgical view) in zoom 3-D acquisition of the 
mitral valve. The prolapse of posterio-medial commisural scallop is evident (arrow). D: 3-D transesophageal echocardiography reconstruction of the 
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umes by planimeter.
In the presence of MR, the rise in left atrial pressure produces 
a reduction of the forward systolic flow at the level of the pul-
monary veins. A systolic flow reversal in the pulmonary veins 
reflects the presence of a significant v-wave and indicates severe 
MR with high specificity. On the other hand, if systolic rever-
sal is absent, severe MR cannot be excluded, because severe in-
competence is not always associated with a prominent v-
wave.20)
Decision Making in Organic MR
Having confirmed the severity of organic MR, indications 
for surgery become the central argument for the subsequent 
follow-up and management. This happens because medical 
treatment in asymptomatic organic MR has not been proved 
to be beneficial in preventing ventricular dysfunction or any 
other complication due to volume overload.11)26) Nowadays, per-
cutaneous repair is promising but conventional surgery (and 
particularly mitral repair) remains the gold standard for the 
treatment of organic MR. Although recently challenged in spe-
cific sub groups of patients,27)28) the superiority of mitral repair 
over replacement is due, among various factors, to the better 
preservation of ventricular function and to the avoidance of 
prosthetic related complications.29)30)
Both American and European guidelines recognize that symp-
toms are per se an indication for surgery, independently of the 
presence of additional risk factors and of the type of surgical 
procedure (repair/replacement). The rationale of waiting for 
symptoms is based (among other considerations) on the fact 
that a perioperative death, or even a sub-optimal repair is diffi-
cult to accept in an asymptomatic patient. Unfortunately, when 
surgery is performed in symptomatic patients, surgical risk in-
creases, and post-surgical outcome remains impaired.31) Con-
versely, when a durable mitral repair is performed in patients 
with no or minimal symptoms, expected survival of operated 
patients is restored to the their expected outcome.31)32) A deci-
sion-making driven by symptoms is particularly challenging 
in the elderly, in those with significant comorbidities, as well 
as in any patients who do not or who cannot engage in physical 
activity intense enough to reveal them. These concerns have en-
couraged the use of exercise test in the setting of valvular heart 
diseases. For instance, previous studies suggested that asymp-
tomatic patients who were nevertheless unable to exercise for 
at least 15 minutes on the treadmill, are characterized by an 
higher incidence of adverse events.33) Useful information can 
also be derived from the more revealing cardiopulmonary ex-
ercise test, since a reduced cardiopulmonary capacity has been 
shown to predict outcome of organic MR.34)
Besides symptoms, an indicator for surgery is the develop-
ment of ventricular dysfunction. While advanced left ventric-
ular dysfunction almost unavoidably causes symptoms, early 
dysfunction can be asymptomatic due to the reduction of the 
after load characterizing physiopathology of MR. Scientific 
guidelines do recommend surgery when left ventricular ejec-
tion fraction drops ≤ 60%, even in asymptomatic patients.11)26) 
We recently analyzed the value of left ventricular ejection frac-
tion in patients enrolled in the international MIDA Registry.35) 
We found that ejection fraction is valuable in defining presence 
and severity of ventricular dysfunction in organic MR. More-
over, our study showed that a large proportion of patients pre-
senting with an ejection fraction between 45% and 60% are 
rarely symptomatic, but they nevertheless display an higher 
mortality compared with those who’s ejection fraction remain 
above 60%. The benefits of surgery remain considerable in both 
these groups, but more favorable in those operated before ven-
tricular dysfunction occurs.35)36) 
The assumption that the prognostic value of ejection fraction 
in MR is sub-optimal due to the reduced afterload has encour-
aged the search for an indicator of ventricular performance of 
loading dependent. Our group recently showed that irrespec-
tive of the presence of symptoms, a left ventricular end-systolic 
diameter ≥ 40 mm represents an independent risk factor for 
adverse outcome, not only under medical management but 
also after mitral surgery.37) Our findings not only indicate to con-
sider surgery in patients with left ventricular end-systolic di-
ameter ≥ 40 mm as recommended by the guidelines, but also 
show that best outcome is achieved in patients operated on be-
fore end-systolic diameter reaches 40 mm.37) 
Concerning an early diagnosis of pre-clinical left ventricular 
dysfunction, exercise echocardiography is gaining increasing 
consideration. In asymptomatic MR, the lack of contractile re-
serve (defined as ≥ 4% increase of left ventricular ejection frac-
tion) has been shown to be a predictor of post-operative ven-
tricular dysfunction;38)39) 
Other indicators of surgery focus on consequences of volume 
overload, including pulmonary hypertension and atrial fibril-
lation. Current guidelines advocate surgery when pulmonary 
artery systolic pressure is ≥ 60 mm Hg during exercise or > 50 
mm Hg at rest.11)26) Pulmonary hypertension represents not 
only a marker of disease severity, but abnormal values of pul-
monary artery systolic pressure could independently affect prog-
nosis by inducing right ventricular dysfunction and functional 
tricuspid regurgitation. Furthermore, elevated pulmonary artery 
pressure can exert direct unfavorable effects through neurohu-
moral activation, and/or impairment of pulmonary ventilation. 
We recently showed that pulmonary hypertension assessed by 
Doppler echocardiography (i.e., right ventricular systolic pres-
sure > 50 mm Hg) is a strong and independent predictor of 
adverse outcome.40) Furthermore, we found that mitral surgery 
does not completely abolish the adverse effects of pulmonary 
hypertension, whereas is particularly beneficial in patients with-
out such complication. 
Atrial fibrillation is strictly linked to MR because MR pro-
duces left atrial enlargement, a precursor of atrial fibrillation 
and also because MR is common particularly in the elderly, who 
are also at high risk for atrial fibrillation.41) Our group showed 
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that the onset of atrial fibrillation is frequent in MR, occurring 
at a rate of approximately 5% per year.30)41) Furthermore, we 
found that the onset of atrial fibrillation leads to increased car-
diac mortality and morbidity.41) Previous data showed that 
when surgery is performed in patients who have already devel-
oped atrial fibrillation, post-surgical outcome is less favorable.31) 
Taken together available data on this subject suggest that left 
atrial protection plays an important role within clinical deci-
sion-making. Our group recently showed that in MR, left atri-
al diameter ≥ 55 mm is associated with increased mortality 
under medical treatment, irrespective of the presence of symp-
toms or left ventricular dysfunction.42) Similarly, left atrial in-
dex (i.e., left atrial volume indexed to body surface area) pre-
dicts long-term outcome.43) 
The brain natriuretic peptide (BNP) and its inactive amino-
terminal portion (NT-proBNP) result from the break down of 
pro-BNP and have vasodilator and diuretic effects. Pizarro et 
al.44) published their prospective experience with asymptomat-
ic patients with organic MR. A cut-off point of 105 pg/mL of 
BNP has been shown to discriminate patients at higher risk of 
adverse events. 
In conclusions, although debate on early surgery is often at-
tracting the attention of the scientific community, it is worth 
remembering that current practice is unfortunately too often 
characterized by an underuse of surgery even in those who 
have a well-established benefit from it,1) and even when surgery 
is performed, repair (the preferred mode of treatment in the vast 
majority of patients) is often underuse.1) 
Taken together, available findings indicate that physicians 
should refer patients with severe MR and a repairable lesion 
early to centers able to achieve a durable repair with a low risk 
of operative mortality. When those requirements cannot be 
achieved at their local institution, physicians should ask for the 
help of centers more experienced in the treatment of MR.26)
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Supplementary Fig. 1. Barlow’ disease. In Barlow’s disease the most 
common finding is diffuse excess tissue, the mitral valve size is generally 
large, and the myxomatous pathological changes usually affects multiple 
segments, eventually resulting in a “floppy mitral valve”. An additional 
typical finding is diffuse chordal elongation and rupture (arrow) (see the 
text for more explanations).
Supplementary Fig. 2. Rheumatic disease. In rheumatic disease the 
valve leaflets are thickened and sometimes calcified as the commissure. 
The chordae are invariably thickened, often fused together, and shorten 
(arrow) (please see the text for more explanation).
Supplementary Fig. 4. Parasternal long axis view (obtained by 
transthoracic echocardiography) showing local remodeling at the level of 
the mitral valve resulting in functional mitral regurgitation from restricted 
leaflet motion and annular dilatation. LA: left atrium, LV: left ventricle.
Supplementary Fig. 3. Trans esophageal echocardiography showing 
a vegetation of the mitral valve (arrow) in a patient presenting with 
infective endocarditis (see text for the details). LA: left atrium, LV: left 
ventricle, RA: right atrium, RV: right ventricle.
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Supplementary Fig. 5. Examination of the mitral valve by transesophageal echocardiography usually implies 4 mid esophageal views (4 
chambers A and B; bicommissural C; 2 chambers D; and long axis E) and the trans gastric basal short axis view. AV: aortic valve, LA: left atrium, LAA: 
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Supplementary Fig. 6. Assessment of the severity of mitral regurgitation based on regurgitant jet area (A and B). The regurgitant jet area can be 
used to assess the severity of MR (C and D, see the text for the explanation). LA: left atrium. 
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Supplementary Fig. 8. Assessment of the severity of mitral regurgitation based on the proximal isovelocity surface area method (see the text for 
more explanation).
